Lawrence Feigenbaum, MD
Dermatology · Cape Girardeau, MONPI 1851633242
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Amgen accounts for 63.7% of it on its own, with 39 other manufacturers making up the rest. Reporting peaked in 2021 at $11,419 and has fallen 79.5% since, to $2,346 in 2025. Among dermatology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 904 payments — averaging $40.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$24K
- AbbVie$3K
- Johnson & Johnson$2K
- Sun Pharmaceutical Industries Inc.$1K
- Lilly USA, LLC$1K
- Novartis$846
- plus $5K from 34 others
What the payments were for
- Speaking & faculty fees$21,25057%
- Travel & lodging$9413%
- Food & beverage$14,19238%
- Education$6012%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Otezla$22,441
How this compares
$36,984 in reported general payments places this provider in the 90th percentile of 263 dermatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Dipropionate | 99 | $3,634 |
| Clobetasol Propionate | 77 | $2,930 |
| Minoxidil | 272 | $2,819 |
| Triamcinolone Acetonide | 181 | $1,539 |
| Doxycycline Hyclate | 43 | $1,127 |
| Tretinoin | 35 | $1,101 |
| Mometasone Furoate | 67 | $1,035 |
| Fluorouracil | 15 | $1,023 |
| Ketoconazole | 80 | $900 |
| Mycophenolate Mofetil | 13 | $883 |
| Dutasteride | 63 | $738 |
| Cephalexin | 18 | $534 |
| Doxepin Hcl | 35 | $481 |
| ValacyclovirValacyclovir Hcl | 17 | $417 |
| Finasteride | 32 | $387 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Cape Girardeau
- Charles MoonCape Girardeau$296K
- Richard LimbertCape Girardeau$12K
- Brian KimSaint Louis$861K
- Elaine SiegfriedSaint Louis$856K
- Craig LeonardiSaint Louis$569K
- Jonathan CleaverKirksville$483K
- Mary GeorgeSaint Louis$400K
- David CleaverKirksville$371K
- Christy RaineyBranson$328K
- John DespainOsage Beach$289K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.